New Website Addresses Epidermal Growth Factor Receptors in Cancer Therapy

AstraZeneca has announced the launch of a new website that will help keep researchers and physicians up to date on the latest information and developments concerning epidermal growth factor receptors (EGFRs).

The website—EGFR-INFO.com—is designed for health and medical professionals only and is password protected. This source of comprehensive information on the role of EGFRs in cancer includes the following sections:

A complete guide to EGFRs and cancer—including the potential role of these receptors in the treatment of cancer—illustrated through graphic animations, which can be requested on CD-ROM

A slide library that can be downloaded from the site and will be expanded and updated regularly as more information becomes available

Reports from international medical congresses and netcasts from important satellite symposia

A weekly update on the latest abstracts and information on EGFRs, with hyperlinks to full articles

A section containing the most frequently asked questions, along with the opportunity to submit questions to be answered by leading experts

The opportunity to search the Medline and CancerLit databases

Hyperlinks to a range of EGFR and cancer sites on the Web

Biological Background

Clinical data suggest that excessive levels of EGFR are linked to poor prognosis, including tumor invasion and development of metastases in some types of cancer. Epidermal growth factor receptors are expressed or overexpressed in a variety of common solid tumors, including non–small-cell lung cancer, colorectal cancer, ovarian cancer, prostate cancer, and gastric cancer.